IBUS vs colonoscopy and enterography for UC and CD
Part of Digestive system clinical trials.
This study compares a newer, possibly greener imaging method (IBUS) with standard colonoscopy and enterography for people with ulcerative colitis (UC) or Crohn's disease (CD). The goal is to see if IBUS is as helpful and produces less waste or carbon emissions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a colonoscopy or other endoscopy procedure as part of your care for ulcerative colitis or Crohn's disease.
- You are able to consent to the procedure.
- You are willing to also undergo an IBUS scan (a type of ultrasound) around the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how well different combinations of drugs calm inflammation in the gut compared to single drugs. It uses tissue samples taken during a colonoscopy to see which approach works best for people with inflammatory bowel disease.
This study compares two ways to examine your colon during a surveillance colonoscopy for IBD: a virtual method using standard light and a dye-based method that sprays a blue dye to highlight abnormal areas. The goal is to see which method is better at finding precancerous changes to help prevent colon cancer.
This study uses a special AI system that analyzes images from a colonoscopy to help doctors better understand how active your ulcerative colitis is and predict how it might progress. If you are scheduled for a routine colonoscopy, this AI tool may help your doctor make more precise treatment decisions.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
This study follows people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who may be taking immunosuppressants (medicines that calm the immune system). Researchers will track how the disease progresses and look at factors like gut bacteria to find ways to predict complications.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.